Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19
Abstract Background Nirmatrelvir/ritonavir (NM/r) is a safe and effective oral antiviral therapeutic used for treatment of mild-to-moderate COVID-19. Case reports described a clinical rebound syndrome whereby individuals experience a relapse of symptoms shortly after completing successful treatment....
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2024-09-01
|
| Series: | BMC Infectious Diseases |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12879-024-09842-8 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|